A detailed history of Traveka Wealth, LLC transactions in Amgen Inc stock. As of the latest transaction made, Traveka Wealth, LLC holds 807 shares of AMGN stock, worth $213,443. This represents 0.13% of its overall portfolio holdings.

Number of Shares
807
Previous 774 4.26%
Holding current value
$213,443
Previous $242 Million 7.54%
% of portfolio
0.13%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$309.38 - $337.38 $10,209 - $11,133
33 Added 4.26%
807 $260 Million
Q2 2024

Jul 16, 2024

BUY
$262.75 - $319.31 $6,306 - $7,663
24 Added 3.2%
774 $242 Million
Q1 2024

Apr 16, 2024

BUY
$268.87 - $324.56 $14,250 - $17,201
53 Added 7.6%
750 $213 Million
Q4 2023

Jan 24, 2024

BUY
$255.7 - $288.46 $178,222 - $201,056
697 New
697 $201 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Traveka Wealth, LLC Portfolio

Follow Traveka Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Traveka Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Traveka Wealth, LLC with notifications on news.